Colchicine for the Treatment of Pericarditis

• Emmerson BT : The management of gout.N. Engl. J. Med., 334, 445–451 (1996).
   PubMed Web of Science ®Google Scholar
• Lange U , SchumannC, SchmidtKL: Current aspects of colchicine therapy. Classical indications and new therapeutic uses.Eur. J. Med. Res., 6, 150–160 (2001).
   PubMed Web of Science ®Google Scholar
• Adler Y , FinkelsteinY, GuindoJet al.: Colchicine treatment for recurrent pericarditis. A decade of experience.Circulation, 97(21), 2183–2185 (1998).
   PubMed Web of Science ®Google Scholar
• Levy M , SpinoM, ReadSE: Colchicine: a state-of-the-art review.Pharmacotherapy, 11(3), 196–211 (1991).
   PubMed Web of Science ®Google Scholar
• Kaplan MM , SchmidC, ProvenzaleDet al.: A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis.Gastroenterology, 117, 1173–1180 (1999).
   PubMed Web of Science ®Google Scholar
• Molad Y : Update on colchicine and its mechanism of action.Curr. Rheumatol. Rep., 3, 252–256 (2002).
   Google Scholar
• Centers for Disease, Control, Prevention (CDC): Deaths from intravenous colchicine resulting from a pharmacy compounding error – Oregon and Washington, 2007. MMWR Morb. Mortal Wkly Rep., 56, 1050 (2007)
   PubMedGoogle Scholar
• Imazio M , BobbioM, CecchiEet al.: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial.Circulation, 112(13), 2012–2016 (2005)
   PubMed Web of Science ®Google Scholar
• Imazio M , BobbioM, CecchiEet al.: Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial.Arch. Intern. Med., 165(17), 1987–1991 (2005).
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E , LevyM: Colchicine prophylaxis in familial Mediterranean fever: Reappraisal after 15 years.Semin. Arthritis Rheum., 20, 241–246 (1991).
   PubMed Web of Science ®Google Scholar
• Zemer D , LivnehA, DanonYL, PrasM, SoharE: Long term colchicine treatment in children with familial Mediterranean fever.Arthritis Rheum., 34, 973–977 (1991).
   PubMed Web of Science ®Google Scholar
• Rodriguez de la Serna A , GuidoJ, MartiV, Bayes de Luna A: Colchicine for recurrent pericarditis (letter). Lancet, 2, 1517 (1987).
   PubMed Web of Science ®Google Scholar
• Guindo J et al. , Rodriguez de la Serna A, Ramio J : Recurrent pericarditis: relief with colchicine. Circulation, 82, 1117–1120 (1990).
   PubMed Web of Science ®Google Scholar
• Adler Y , Zandman-GoddardG, RavidMet al.: Usefulness of colchicine in preventing recurrences of pericarditis.Am. J. Cardiol., 73, 916–917 (1994).
   PubMed Web of Science ®Google Scholar
• Millaire A , de Groote P, Decoulx E, Goullard L, Ducloux G: Treatment of recurrent pericarditis with colchicine. Eur. Heart J., 15, 120–124 (1994).
   PubMed Web of Science ®Google Scholar
• Imazio M , DemichelisB, ParriniIet al.: Management, risk factors, and outcomes in recurrent pericarditis.Am. J. Cardiol., 96(5), 736–739 (2005).
   PubMed Web of Science ®Google Scholar
• Artom G , Koren-MoragN, SpodickDHet al.: Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis.Eur. Heart J., 26(7), 723–727 (2005).
   PubMed Web of Science ®Google Scholar
• Maisch B , SeferovicPM, RisticADet al.; Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology: Guidelines on the diagnosis and management of pericardial diseases. Eur. Heart J., 25(7), 587–610 (2004).
   PubMed Web of Science ®Google Scholar
• Soler-Soler J , Sagrista-SauledaJ, Permanyer-MiraldaG: Relapsing pericarditis.Heart, 90(11), 1364–1368 (2004).
   PubMed Web of Science ®Google Scholar
• Brucato A , BrambillaG, AdlerY, SpodickDH, CanesiB: Therapy for recurrent acute pericarditis: a rheumatological solution?Clin. Exp. Rheumatol., 24(1), 45–50 (2006).
   PubMed Web of Science ®Google Scholar
• Millaire A , DuclouxG: Treatment of acute or recurrent pericarditis with colchicine (letter).Circulation, 83, 1458–1459 (1991).
   PubMed Web of Science ®Google Scholar
• Imazio M , TrincheroR, ShabetaiR: Pathogenesis, management, and prevention of recurrent pericarditis.J. Cardiovasc. Med., 8(6), 404–410 (2007).
   Google Scholar
• Imazio M , CecchiE, CorrendoLet al.: Treatment of refractory recurrent pericarditis. Case report and review.J. Cardiovasc. Med., 8(9), 748–753 (2007).
   Google Scholar
• Imazio M , BrucatoA, AdlerYet al.: Prognosis of idiopathic recurrent pericarditis as determined from previously published reports.Am. J. Cardiol., 100(6), 1026–1028 (2007).
   PubMed Web of Science ®Google Scholar
• Wallace SL , SingerJZ, DuncanGJet al.: Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout.J. Rheumatol., 18(2), 264–269 (1991).
   PubMed Web of Science ®Google Scholar
• Adler Y , SpodickDH, ShabetaiR, BrucatoA: Can colchicine prevent recurrence of new-onset acute pericarditis?Nat. Clin. Pract. Cardiovasc. Med., 3, 78–79 (2006).
   PubMedGoogle Scholar
• Brucato A , AdlerY, SpodickDH: Letter regarding article by Imazio et al., ‘colchicine in addition to conventional therapy for acute pericarditis‘.Circulation, 113, E693, author reply E693–E694 (2006).
   PubMed Web of Science ®Google Scholar
• Bjornsson TD , CallaghanJT, EinolfHJet al.: The conduct of in vitro and in vivo drug–drug interaction studies: a PhRMA perspective.J. Clin. Pharmacol., 43(5), 443–469 (2003).
   PubMed Web of Science ®Google Scholar
• Menta R , RossiE, GuarigliaAet al.: Reversible acute cyclosporine nephrotoxicity induced by colchicine administration.Nephrol. Dial. Transplant., 2, 380–381 (1987).
   PubMedGoogle Scholar
• Rieger EH , HalaszNA, WahlstromHE: Colchicine neuromyopathy after renal transplantation.Transplantation, 49, 1196–1198 (1990).
   PubMed Web of Science ®Google Scholar
• Rumpf KW , HenningHV: Is myopathy in renal transplant patients induced by cyclosporine or colchicine?Lancet, 335, 800–801 (1990).
   PubMed Web of Science ®Google Scholar
• Yussim A , Bar-NathanM, LustigSet al.: Gastrointestinal, hepatorenal, and neuromuscular toxicity caused by cyclosporine–colchicine interaction in renal transplantation.Transplant. Proc., 26, 2825–2826 (1994).
   PubMed Web of Science ®Google Scholar
• Rollot F , PajotO, Chauvelot-MoachonLet al.: Acute colchicine intoxication during clarithromycin administration.Ann. Pharmacother., 38(12), 2074–2077 (2004).
   PubMed Web of Science ®Google Scholar
• Cheng VC , HoPL, YuenKY: Two probable cases of serious drug interaction between clarithromycin and colchicine.South. Med. J., 98(8), 811–813 (2005).
   PubMed Web of Science ®Google Scholar
• Hung IF , WuAK, ChengVCet al.: Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study.Clin. Infect. Dis., 41(3), 291–300 (2005).
   PubMed Web of Science ®Google Scholar
• Justiniano M , DoldS, EspinozaLR: Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine.J. Clin. Rheumatol., 13, 266–268 (2007).
   PubMed Web of Science ®Google Scholar
• Francis L , BonillaE, SoforoEet al.: Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin.Clin. Rheumatol., 27, 129–131 (2008).
   PubMed Web of Science ®Google Scholar
• Baker SK , GoodwinS, SurMet al.: Cytoskeletal myotoxicity from simvastatin and colchicine.Muscle Nerve, 30, 799–802 (2004).
   PubMed Web of Science ®Google Scholar
• Hsu WC , ChenWH, ChangMTet al.: Colchicine-induced acute myopathy in a patient with concomitant use of simvastatin.Clin. Neuropharmacol., 25, 266–268 (2002).
   PubMed Web of Science ®Google Scholar
• Tufan A , DedeDS, CavusSet al.: Rhabdomyolysis in a patient treated with colchicine and atorvastatin.Ann. Pharmacother., 40, 1466–1469 (2006).
   PubMed Web of Science ®Google Scholar
• Phanish MK , KrishnamurthyS, BloodworthLL: Colchicine-induced rhabdomyolysis.Am. J. Med., 114, 166–167 (2003).
   PubMed Web of Science ®Google Scholar
• Atasoyu EM , EvrenkayaTR, SolmazgulE: Possible colchicine rhabdomyolysis in a fluvastatin-treated patient.Ann. Pharmacother., 39, 1368–1369 (2005).
   PubMed Web of Science ®Google Scholar
• Torgovnick J , SethiN, ArsuraE: Colchicine and HMG Co-A reductase inhibitors induced myopathy – a case report.Neurotoxicology, 27, 1126–1127 (2006).
   PubMed Web of Science ®Google Scholar
• Alayli G , CengizK, CanturkFet al.: Acute myopathy in a patient with concomitant use of pravastatin and colchicine.Ann. Pharmacother., 39, 1358–1361 (2005).
   PubMed Web of Science ®Google Scholar
• Melli G , ChaudhryV, CornblathDR: Rhabdomyolysis: an evaluation of 475 hospitalized patients.Medicine (Baltimore), 84, 377–385 (2005).
   PubMed Web of Science ®Google Scholar
• Tateishi T , SoucekP, CaracoYet al.: Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation.Biochem. Pharmacol., 53, 111–116 (1997).
   PubMed Web of Science ®Google Scholar
• Dvorak Z , ModrianskyM, Pichard-GarciaLet al.: Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation.Mol. Pharmacol., 64, 160–169 (2003).
   PubMed Web of Science ®Google Scholar
• Takikawa H , SanoN, AkimotoKet al.: Effects of colchicine and phenothiazine on biliary excretion of organic anions in rats.J. Gastroenterol. Hepatol., 13, 427–432 (1998).
   PubMed Web of Science ®Google Scholar
• Imazio M , CecchiE, DemichelisBet al.; COPPS Investigators: Rationale and design of the COPPS trial: a randomised, placebo-controlled, multicentre study on the use of colchicine for the primary prevention of postpericardiotomy syndrome. J. Cardiovasc. Med., 8(12), 1044–1048 (2007).
   Google Scholar
• Imazio M , CecchiE, IernaS, Trinchero R;on behalf of the ICAP Investigators: Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design and rationale. J. Cardiovasc. Med., 8(8), 613–617 (2007).
   Google Scholar
• Imazio M , CecchiE, IernaS, Trinchero R; on behalf of the CORP Investigators: CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials: Two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis. Study design and rationale. J. Cardiovasc. Med., 8(10), 830–834(2007).
   Google Scholar

Website

• Questions and answers about FDAs enforcement action against unapproved injectable colchicine products www.fda.gov/cder/drug/unapproved_drugs/colchicine_qa.htm
   Google Scholar